Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) Payments to Acquire Productive Assets

2.5 / 5 stars · 59/119 Roast Me

INFUSYSTEM HOLDINGS, INC Payments to Acquire Productive Assets

INFUSYSTEM HOLDINGS, INC (INFU) reported Payments to Acquire Productive Assets of $4.54 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireProductiveAssets · last filed 2020-05-15

  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for the quarter ending 2020-03-31 was $4.54M, a 28.32% increase year-over-year.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for the quarter ending 2019-09-30 was $8.53M, a 379.58% increase year-over-year.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for the quarter ending 2019-06-30 was $4.36M, a 168.52% increase year-over-year.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for the quarter ending 2019-03-31 was $3.54M, a 215.63% increase year-over-year.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for fiscal 2018 was $8.02M, a 202.49% increase from fiscal 2017.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for fiscal 2017 was $2.65M, a 48.01% decline from fiscal 2016.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for fiscal 2016 was $5.10M, a 21.51% increase from fiscal 2015.
  • INFUSYSTEM HOLDINGS, INC payments to acquire productive assets for fiscal 2015 was $4.20M, a 0.74% increase from fiscal 2014.
Period endPayments to Acquire Productive Assets 3 monthPayments to Acquire Productive Assets 3 month as first filedPayments to Acquire Productive Assets 6 monthPayments to Acquire Productive Assets 6 month as first filedPayments to Acquire Productive Assets 9 monthPayments to Acquire Productive Assets 9 month as first filedPayments to Acquire Productive Assets 12 monthPayments to Acquire Productive Assets 12 month as first filed
2020-03-31$4.54M
10-Q · filed 2020-05-15
2019-09-30$8.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$12.88M
derived: sum of 2 quarters · filed 2019-11-14
$16.42M
10-Q · filed 2019-11-14
$19.92M
derived: sum of 4 quarters · filed 2020-05-15
2019-06-30$4.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$7.89M
10-Q · filed 2019-08-14
$11.39M
derived: sum of 3 quarters · filed 2020-05-15
$13.17M
derived: sum of 4 quarters · filed 2020-05-15
2019-03-31$3.54M
10-Q · filed 2020-05-15
$7.04M
derived: sum of 2 quarters · filed 2020-05-15
$8.81M
derived: sum of 3 quarters · filed 2020-05-15
$10.44M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
$5.28M
derived: sum of 2 quarters · filed 2019-11-14
$6.90M
derived: sum of 3 quarters · filed 2019-11-14
$8.02M
10-K · filed 2019-03-22
2018-09-30$1.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$3.40M
derived: sum of 2 quarters · filed 2019-11-14
$4.52M
10-Q · filed 2019-11-14
$4.96M
10-Q · filed 2018-11-13
$4.34M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$1.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$2.74M
10-Q · filed 2019-08-14
$2.93M
10-Q · filed 2018-08-14
$2.57M
derived: sum of 3 quarters · filed 2019-08-14
$3.50M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$1.12M
10-Q · filed 2019-05-15
$1.21M
10-Q · filed 2018-05-14
$943.00K
derived: sum of 2 quarters · filed 2019-05-15
$1.88M
derived: sum of 3 quarters · filed 2019-05-15
$2.76M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31-$177.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
$759.00K
derived: sum of 2 quarters · filed 2019-03-22
$1.64M
derived: sum of 3 quarters · filed 2019-03-22
$2.65M
10-K · filed 2019-03-22
$3.30M
10-K · filed 2018-03-19
2017-09-30$936.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$1.81M
derived: sum of 2 quarters · filed 2018-11-13
$2.83M
10-Q · filed 2018-11-13
$933.00K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$878.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$1.89M
10-Q · filed 2018-08-14
-$3.00K
derived: sum of 3 quarters · filed 2018-08-14
-$193.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$1.01M
10-Q · filed 2018-05-14
-$881.00K
derived: sum of 2 quarters · filed 2018-05-14
-$1.07M
derived: sum of 3 quarters · filed 2018-05-14
$2.84M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
-$2.09M
derived: sum of 2 quarters · filed 2018-03-19
$1.83M
derived: sum of 3 quarters · filed 2018-03-19
$5.10M
10-K · filed 2018-03-19
2016-09-30-$190.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$3.72M
derived: sum of 2 quarters · filed 2017-11-13
$7.00M
10-Q · filed 2017-11-13
$1.80M
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30$3.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$7.19M
10-Q · filed 2017-08-09
$2.00M
derived: sum of 3 quarters · filed 2017-08-09
$1.91M
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$3.27M
10-Q · filed 2017-05-15
-$1.92M
derived: sum of 2 quarters · filed 2017-05-15
-$2.00M
derived: sum of 3 quarters · filed 2017-05-15
$3.80M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$5.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
-$5.28M
derived: sum of 2 quarters · filed 2017-03-22
$528.00K
derived: sum of 3 quarters · filed 2017-03-22
$4.20M
10-K · filed 2017-03-22
2015-09-30-$84.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-12-12
$5.72M
derived: sum of 2 quarters · filed 2016-12-12
$9.39M
10-Q · filed 2016-12-12
$6.39M
derived: sum of 4 quarters · filed 2016-12-12
2015-06-30$5.80M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-12-12
$9.47M
10-Q/A · filed 2016-12-12
$6.47M
derived: sum of 3 quarters · filed 2016-12-12
$9.12M
derived: sum of 4 quarters · filed 2016-12-12
2015-03-31$3.67M
10-Q/A · filed 2016-12-12
$669.00K
derived: sum of 2 quarters · filed 2016-12-12
$3.31M
derived: sum of 3 quarters · filed 2016-12-12
$6.71M
derived: sum of 4 quarters · filed 2016-12-12
2014-12-31-$3.00M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12
-$357.00K
derived: sum of 2 quarters · filed 2016-12-12
$3.04M
derived: sum of 3 quarters · filed 2016-12-12
$4.17M
10-K/A · filed 2016-12-12
2014-09-30$2.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$6.04M
derived: sum of 2 quarters · filed 2014-11-10
$7.17M
10-Q · filed 2014-11-10
$9.73M
derived: sum of 4 quarters · filed 2014-11-10
2014-06-30$3.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$4.52M
10-Q · filed 2014-08-01
$7.09M
derived: sum of 3 quarters · filed 2014-08-01
$7.92M
derived: sum of 4 quarters · filed 2014-11-10
2014-03-31$1.13M
10-Q · filed 2014-05-05
$3.69M
derived: sum of 2 quarters · filed 2014-05-05
$4.53M
derived: sum of 3 quarters · filed 2014-11-10
$5.31M
derived: sum of 4 quarters · filed 2014-11-10
2013-12-31$2.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11
$3.40M
derived: sum of 2 quarters · filed 2014-11-10
$4.18M
derived: sum of 3 quarters · filed 2014-11-10
$5.96M
10-K · filed 2014-03-11
2013-09-30$832.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$1.62M
derived: sum of 2 quarters · filed 2014-11-10
$3.40M
10-Q · filed 2014-11-10
$5.63M
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30$787.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$2.56M
10-Q · filed 2014-08-01
$4.79M
derived: sum of 3 quarters · filed 2014-08-01
$6.14M
derived: sum of 4 quarters · filed 2014-08-01
2013-03-31$1.78M
10-Q · filed 2014-05-05
$4.01M
derived: sum of 2 quarters · filed 2014-05-05
$5.36M
derived: sum of 3 quarters · filed 2014-05-05
$6.22M
derived: sum of 4 quarters · filed 2014-05-05
2012-12-31$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11
$3.58M
derived: sum of 2 quarters · filed 2014-03-11
$4.45M
derived: sum of 3 quarters · filed 2014-03-11
$6.54M
10-K · filed 2014-03-11
2012-09-30$1.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$2.22M
derived: sum of 2 quarters · filed 2013-11-12
$4.31M
10-Q · filed 2013-11-12
$3.15M
10-Q · filed 2012-11-14
$9.23M
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30$868.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
$2.96M
10-Q · filed 2013-08-13
$1.73M
10-Q · filed 2012-08-08
$7.88M
derived: sum of 3 quarters · filed 2013-08-13
$8.79M
derived: sum of 4 quarters · filed 2013-08-13
2012-03-31$2.10M
10-Q · filed 2013-05-13
$1.21M
10-Q · filed 2012-05-21
$7.01M
derived: sum of 2 quarters · filed 2013-05-13
$7.92M
derived: sum of 3 quarters · filed 2013-05-13
$7.87M
derived: sum of 4 quarters · filed 2013-05-13
2011-12-31$4.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$5.83M
derived: sum of 2 quarters · filed 2013-03-28
$5.77M
derived: sum of 3 quarters · filed 2013-03-28
$8.21M
10-K · filed 2013-03-28
$4.16M
10-K · filed 2012-03-16
2011-09-30$912.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$857.00K
derived: sum of 2 quarters · filed 2012-11-14
$3.29M
10-Q · filed 2012-11-14
$4.35M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30-$55.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$2.38M
10-Q · filed 2012-08-08
$3.44M
derived: sum of 3 quarters · filed 2012-08-08
$4.48M
derived: sum of 4 quarters · filed 2012-08-08
2011-03-31$2.44M
10-Q · filed 2012-05-21
$3.49M
derived: sum of 2 quarters · filed 2012-05-21
$4.54M
derived: sum of 3 quarters · filed 2012-05-21
2010-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16
$2.10M
derived: sum of 2 quarters · filed 2012-03-16
$2.44M
10-K · filed 2012-03-16
2010-09-30$1.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$1.39M
10-Q · filed 2011-11-14
2010-06-30$343.00K
10-Q · filed 2011-08-15
2009-12-31$4.61M
10-K · filed 2012-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37